These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 17387734)

  • 1. The role of tumor microenvironment in prostate cancer bone metastasis.
    Morrissey C; Vessella RL
    J Cell Biochem; 2007 Jul; 101(4):873-86. PubMed ID: 17387734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
    Chung LW; Baseman A; Assikis V; Zhau HE
    J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteases, growth factors, chemokines, and the microenvironment in prostate cancer bone metastasis.
    Bonfil RD; Chinni S; Fridman R; Kim HR; Cher ML
    Urol Oncol; 2007; 25(5):407-11. PubMed ID: 17826661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A paradigm for the treatment of prostate cancer bone metastases based on an understanding of tumor cell-microenvironment interactions.
    Loberg RD; Gayed BA; Olson KB; Pienta KJ
    J Cell Biochem; 2005 Oct; 96(3):439-46. PubMed ID: 15988761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis of osteoblastic bone metastases from prostate cancer.
    Ibrahim T; Flamini E; Mercatali L; Sacanna E; Serra P; Amadori D
    Cancer; 2010 Mar; 116(6):1406-18. PubMed ID: 20108337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate tumor-stroma interaction: molecular mechanisms and opportunities for therapeutic targeting.
    Sung SY; Chung LW
    Differentiation; 2002 Dec; 70(9-10):506-21. PubMed ID: 12492493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mineralized human primary osteoblast matrices as a model system to analyse interactions of prostate cancer cells with the bone microenvironment.
    Reichert JC; Quent VM; Burke LJ; Stansfield SH; Clements JA; Hutmacher DW
    Biomaterials; 2010 Nov; 31(31):7928-36. PubMed ID: 20688384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of MDA-BF-1, a secreted isoform of ErbB3, in metastatic prostate cancer cells and activated osteoblasts in bone marrow.
    Vakar-Lopez F; Cheng CJ; Kim J; Shi GG; Troncoso P; Tu SM; Yu-Lee LY; Lin SH
    J Pathol; 2004 Jun; 203(2):688-95. PubMed ID: 15141384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone metastasis in prostate cancer: molecular and cellular mechanisms (Review).
    Ye L; Kynaston HG; Jiang WG
    Int J Mol Med; 2007 Jul; 20(1):103-11. PubMed ID: 17549396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of tumor metastasis to the bone: challenges and opportunities.
    Reddi AH; Roodman D; Freeman C; Mohla S
    J Bone Miner Res; 2003 Feb; 18(2):190-4. PubMed ID: 12568395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate carcinoma bone-stroma interaction and its biologic and therapeutic implications.
    Chung LW
    Cancer; 2003 Feb; 97(3 Suppl):772-8. PubMed ID: 12548574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The bone microenvironment in metastasis; what is special about bone?
    Bussard KM; Gay CV; Mastro AM
    Cancer Metastasis Rev; 2008 Mar; 27(1):41-55. PubMed ID: 18071636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer bone metastases promote both osteolytic and osteoblastic activity.
    Keller ET; Brown J
    J Cell Biochem; 2004 Mar; 91(4):718-29. PubMed ID: 14991763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arachidonic acid modulates the crosstalk between prostate carcinoma and bone stromal cells.
    Angelucci A; Garofalo S; Speca S; Bovadilla A; Gravina GL; Muzi P; Vicentini C; Bologna M
    Endocr Relat Cancer; 2008 Mar; 15(1):91-100. PubMed ID: 18310278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stromal factors involved in prostate carcinoma metastasis to bone.
    Cooper CR; Chay CH; Gendernalik JD; Lee HL; Bhatia J; Taichman RS; McCauley LK; Keller ET; Pienta KJ
    Cancer; 2003 Feb; 97(3 Suppl):739-47. PubMed ID: 12548571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kallikrein 4 is a potential mediator of cellular interactions between cancer cells and osteoblasts in metastatic prostate cancer.
    Gao J; Collard RL; Bui L; Herington AC; Nicol DL; Clements JA
    Prostate; 2007 Mar; 67(4):348-60. PubMed ID: 17221837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of prostate cancer growth in bone microenvironments.
    Edlund M; Sung SY; Chung LW
    J Cell Biochem; 2004 Mar; 91(4):686-705. PubMed ID: 14991761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Wnts in prostate cancer bone metastases.
    Hall CL; Kang S; MacDougald OA; Keller ET
    J Cell Biochem; 2006 Mar; 97(4):661-72. PubMed ID: 16447163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic process of prostate cancer metastasis to bone.
    Tantivejkul K; Kalikin LM; Pienta KJ
    J Cell Biochem; 2004 Mar; 91(4):706-17. PubMed ID: 14991762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the stromal microenvironment in prostate cancer.
    Condon MS
    Semin Cancer Biol; 2005 Apr; 15(2):132-7. PubMed ID: 15652458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.